0000899243-20-023394.txt : 20200825
0000899243-20-023394.hdr.sgml : 20200825
20200825194203
ACCESSION NUMBER: 0000899243-20-023394
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200821
FILED AS OF DATE: 20200825
DATE AS OF CHANGE: 20200825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Serafin Andrew
CENTRAL INDEX KEY: 0001821460
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39450
FILM NUMBER: 201133887
MAIL ADDRESS:
STREET 1: 630 W. GERMANTOWN PIKE
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc.
CENTRAL INDEX KEY: 0001802665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822279923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: (484) 539-9800
MAIL ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-21
0
0001802665
Harmony Biosciences Holdings, Inc.
HRMY
0001821460
Serafin Andrew
630 W. GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING
PA
19462
0
1
0
0
Chief Business Officer
Common Stock
2020-08-21
4
C
0
32214
A
32214
D
Common Stock
2020-08-21
4
C
0
6871
A
39085
D
Series A Preferred Stock
2020-08-21
4
C
0
207869
0.00
D
Common Stock
32214
0
D
Series C Preferred Stock
2020-08-21
4
C
0
51681
0.00
D
Common Stock
6871
0
D
Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering.
Includes 7,869 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020.
Includes 661 shares received upon the payment of an in-kind dividend on the Series C Preferred Stock on August 21, 2020.
/s/ Stephanie Wisdo, Attorney-in-fact for Andrew Serafin
2020-08-25